We know deals are due but the share price is stagnating, which seems surprising given that Craig is aiming to be a multi-billion dollar company. Perhaps punters are factoring in a CR since the 4c said there would be a CR:
"The Company anticipates that it will raise additional capital during the September 2022 quarter".
So, from the prospective investor's viewpoint, these are the short-term (by end of year) catalysts (up and down) that I'm seeing:
The first two would be sell the news (unless the CR was an investment at a premium which is unlikely prior to FDA approval) and the second two would be buy the news.
- Something from the $6.3m (USD) pipeline of deals
- CR from sophs or shareholders, or from debt funding
- FDA approval
- US listing
Any other catalysts? Also, does anyone know what it costs to list in the US?
- Forums
- ASX - By Stock
- CDX
- General Forum
General Forum, page-569
-
- There are more pages in this discussion • 1,142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.06M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 11940 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.056 |
1 | 15000 | 0.054 |
3 | 231104 | 0.053 |
3 | 373076 | 0.052 |
3 | 230000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 11940 | 3 |
0.061 | 33080 | 1 |
0.062 | 83300 | 1 |
0.063 | 130000 | 1 |
0.064 | 130000 | 1 |
Last trade - 16.12pm 14/10/2024 (20 minute delay) ? |
Featured News
CDX (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online